In silico and in vitro assessment of TP53, ATM, RAD51, and BAX genes in gastric cancer and their contribution to radiotherapy resistance
Abstract Background Gastric cancer remains a leading cause of cancer-related morbidity and mortality worldwide. The genetic factors contributing to gastric cancer progression and resistance to therapies, particularly radiotherapy, are not fully understood. TP53, ATM, RAD51, and BAX are genes involve...
Saved in:
| Main Authors: | Junwei Zhang, Pengtao He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-025-00496-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of PDK modulates radiotherapy resistance in gastric cancer
by: Qi Zhang, et al.
Published: (2025-05-01) -
Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy
by: Jing Xu, et al.
Published: (2020-07-01) -
Evaluating the benefit of adjuvant radiotherapy after extensive lymph node dissection for gastric cancer: a single-institute retrospective study
by: Yu-Nong Wang, et al.
Published: (2021-01-01) -
POLYMORPHISM OF THE TP53 GENE IN PATIENTS WITH GASTRIC CANCER IN PROSPECTIVE AND CLINICAL CASE-CONTROL STUDIES
by: A. V. Belkovets, et al.
Published: (2018-07-01) -
LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations
by: Suzeng Wang, et al.
Published: (2025-02-01)